Orthopedia Stock Price, News & Analysis

OrthoPediatrics Corp. (KIDS) announced its entry into the U.K. market with the launch of two advanced surgical systems. The Pediatric Nailing Platform | FEMUR received U.K. regulatory clearance, offering specialized solutions for pediatric femoral fractures. Additionally, the ApiFix system, designed for adolescent idiopathic scoliosis, allows for less invasive procedures and faster recovery times. President Dave Bailey emphasized the company's commitment to global expansion and providing innovative orthopedic solutions specifically for pediatrics.

OrthoPediatrics Corp. (Nasdaq: KIDS) has been honored as the 2020 Corporate Champion of the Year by the World Pediatric Project (WPP). This award recognizes corporations dedicated to improving children's access to critical healthcare. OrthoPediatrics has contributed significantly by providing pediatric implants and financial support, helping over 100 children receive necessary surgeries. CEO Mark Throdahl expressed gratitude for the honor and reiterated the company's commitment to advancing pediatric orthopedic care. The company offers 35 surgical systems across various pediatric orthopedic categories, operating in the U.S. and 43 other countries.

OrthoPediatrics Corp. (Nasdaq: KIDS) reported third-quarter 2020 revenue of $22.2 million, a 7.0% increase from $20.7 million in Q3 2019. U.S. revenue surged 16.7% to $19.6 million, accounting for 88.2% of total revenue. The company also achieved a 167% increase in first-time users for its Orthex product year-to-date. However, international revenue fell 33.8% to $2.6 million. Adjusted EBITDA improved to $1.1 million, up from $0.7 million in the previous year. Overall, the company remains optimistic about maintaining growth despite challenges posed by the COVID-19 pandemic.

Telos Partners LLC, a subsidiary of OrthoPediatrics Corp. (NASDAQ: KIDS), has appointed Erik Waldorff, PhD, as Director of Science & Innovation. With over 17 years of experience in orthopedic and medical device development, Waldorff aims to enhance Telos' scientific services and support commercialization objectives. His background in Biomedical Engineering, coupled with business acumen, positions him to drive innovative solutions for client partners. This leadership change is expected to strengthen Telos's offerings in regulatory, reimbursement, and clinician adoption fields.

OrthoPediatrics Corp. (Nasdaq: KIDS) announced participation in three virtual investor conferences in November 2020. Key executives, including CEO Mark Throdahl and COO Fred Hite, will represent the company. The events include the Credit Suisse 29th Annual Virtual Healthcare Conference on November 11, Stifel 2020 Virtual Healthcare Conference on November 18, and Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum on November 19. Investors can access the audio webcast on OrthoPediatrics' investor relations site.

OrthoPediatrics Corp. (NASDAQ: KIDS) will release its third quarter 2020 financial results on November 4, 2020, after the market closes. A conference call to discuss these results is scheduled for November 5, 2020, at 8:00 a.m. ET. Interested participants can join the call using the provided domestic and international dial-in numbers. OrthoPediatrics, founded in 2006, focuses on pediatric orthopedics, offering 35 surgical systems across multiple categories and serving markets in the U.S. and 43 other countries.

OrthoPediatrics Corp. (KIDS) announced its support for the 3rd Annual PediOrtho WEST Resident Education Course, scheduled for October 16-17 in Sacramento, California. The course aims to provide orthopedic residents with essential training in pediatric orthopedic techniques through both lectures and hands-on labs, facilitated by expert surgeons. President David Bailey emphasized the company's commitment to advancing pediatric orthopedic education globally, enhancing outcomes for aspiring surgeons.

OrthoPediatrics Corp. (Nasdaq: KIDS) announces continued support for the Scoliosis Research Society (SRS) with Gold Level sponsorship for its 55th Annual Meeting, running virtually from September 9-13. Additionally, the company will be a Platinum Level Sponsor for the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) 74th Annual Meeting from September 23-26. OrthoPediatrics will offer educational grants and scholarships for physicians attending these events, contributing to discussions and showcasing its products through virtual exhibits.

OrthoPediatrics Corp. (Nasdaq: KIDS) announced participation in the Morgan Stanley 18th Annual Global Healthcare Conference on September 15, 2020. Key executives, including CEO Mark Throdahl and CFO Fred Hite, will engage in a fireside chat and one-on-one meetings starting at 4:15 PM ET. The event will take place virtually, with an audio webcast accessible on the company’s investor relations website. OrthoPediatrics specializes in pediatric orthopedic products, boasting 35 surgical systems for trauma, scoliosis, and sports medicine across 43 countries.